Prevalence of depressive symptoms in metabolic syndrome

Authors

  • Sonia María López University of Antioquia
  • Jesús Alveano
  • Jaime Carranza

DOI:

https://doi.org/10.17533/udea.rfnsp.841

Keywords:

depression, metabolic syndrome, hypertension, dislipidemia

Abstract

Depression has been related with alterations of glucose metabolism, hypertension, hypercholesterolemia, adiposity and dislipidemias, which constitute the metabolic syndrome (MS). Objective: to determine the frequency of depressive symptoms in patients with MS. Material and methods: an observational, descriptive, transverse study was carried out in 101 patients with MS (69 women and 32 men). The Beck inventory for depression was applied. Vasodilatation in the brachial artery and the thickness of the carotid intimae-media were evaluated by means of ultrasonographic measurement. Abdominal perimeter, trygliceridemia, cholesterolemia and insulin resistance were calculated. The statistic treatment was performed by means of descriptive and inferential through mean, standard deviation, and correlation proofs. Insulin resistance was calculated by the HOMA method. Results: prevalence of depressive symptoms: 46.34% between patients with MS (correlation of 0.42 significative at p= 0.05). A higher number of components of the syndrome correlates with higher severity of the depression. Depressive symptoms were associated to a higher insulin resistance, low levels of C-HDL, hypertension and carotid atherosclerosis. Conclusion: depression has a high prevalence in the MS and its associates with a higher number of metabolic and vascular disturbances.
|Abstract
= 470 veces | PDF (ESPAÑOL (ESPAÑA))
= 137 veces|

Downloads

Download data is not yet available.

Author Biographies

Sonia María López, University of Antioquia

Surgeon, candidate for a master's degree in health sciences, Faculty of Medical and Biological Sciences Dr. Ignacio Chávez

Jesús Alveano

Surgeon; Doctor of Science in Clinical Psychology; research professor, Division of Postgraduate Studies, Faculty of Medical and Biological Sciences Dr. Ignacio Chávez, Universidad Michoacana de San Nicolás de Hidalgo

Jaime Carranza

Surgeon, Internal Medicine Specialist, Master of Science in Clinical Pharmacology; career professor, Faculty of Medical and Biological Sciences Dr. Ignacio Chávez, Michoacana University of San Nicolás de Hidalgo

References

(1). �essler RC, Berglund P, Demler O, Jin R, Merikangas �R, �al-�essler RC, Berglund P, Demler O, Jin R, Merikangas �R, �al-ters EE. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replica-tion. Arch Gen Psychiatry. 2005 Jun; 62(6):590-602. DOI: https://doi.org/10.1001/archpsyc.62.6.593

(2). The �HO �orld Mental Health Survey Consortium. Prevalence, severity, and unmet need for treatment of mental disorders in the �orld Health Organization �orld Mental Health Surveys. J Am Med Assoc 2004; 291(21):2581-90 DOI: https://doi.org/10.1001/jama.291.21.2581

(3). Gómez C, Bohórquez A, Pinto D, Gil JFA, Rondón M, Díaz N. Prevalencia de depresión y factores asociados con ella en la pobla-ción colombiana. Rev Panam Salud Publica 2004; 16(6):378-386. DOI: https://doi.org/10.1590/S1020-49892004001200003

(4). Alberti �G, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a �HO consultation. Diabet Med. 1998; 15:539-553. DOI: https://doi.org/10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S

(5). Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults. Executive Summary of the third re-port of the National Cholesterol Education Program (NCEP). J Am Med Assoc 2001; 285(19):2486-97. } DOI: https://doi.org/10.1001/jama.285.19.2486

(6). Diamant M, Tushuizen ME. The Metabolic Syndrome and En-dothelial Dysfunction: Common Highway to Type 2 Diabetes and CVD?. Curr Diab Rep 2006; 6(4):279-286. DOI: https://doi.org/10.1007/s11892-006-0061-4

(7). Aguilar CA, Rojas R, Gómez FJ, Valles V, Ríos JM, Franco A, et al. Analysis of the agreement between the �orld Health Organi-zation criteria and the National Cholesterol Education Program-III definition of the metabolic syndrome. Results from a popula-tion based study. Diabetes Care 2003; 26:1251-57. DOI: https://doi.org/10.2337/diacare.26.5.1635

(8). Lakka HM, Laaksonen DE, Lakka TA, Niskanen L�, �umpusalo E, Tuomilehto J, et al. The metabolic syndrome and total cardio-vascular disease mortality in middle-aged men. J Am Med Assoc 2002; 288(21):2709-16. DOI: https://doi.org/10.1001/jama.288.21.2709

(9). Villegas A, Botero JF, Arango IC, Arias S, Toro MM. Prevalen-cia del síndrome metabólico en El Retiro, Colombia. IATREIA 2003; 16(4):291-297

(10). Soto V, Vergara E, Neciosup E. Prevalencia y Factores de Riesgo de Síndrome Metabólico en Población adulta del Departamento de Lambayeque, Perú-2004. Rev. perú. med. exp. salud pública 2005; 22(4):254-261

(11). Hernández L, Téllez JF, Garduño J, González E. Factors asso-ciated with therapy noncompliance in type-2 diabetes patients. Salud Pública Mex 2003; 45(3):191-197 DOI: https://doi.org/10.1590/S0036-36342003000300008

(12). Bundo M, Auba J, Massons J, Trilla MC, Pérez R, Pérez AM. An-siedad y depresión en pacientes diabéticos tipo II. Aten Primaria 1996; 17:58-62.

(13). Ruiz LG, Vázquez F, Corlay I, Báez A, Mandujano R, Islas S, Revilla MC. Depresión en pacientes diabéticos y su relación con el control metabólico medido por HbA1c. Psiquiatría 2004; 12(3):66-71

(14). Valencia FJ, Ochoa MG, Soriano AM. Correlación de leucocitos y depresión en pacientes diabéticos. Psiquis 2002; 6(11):194-199

(15). Pollex RL, Al-Shali KZ, House AA, Spence JD, Fenster A, Ma-makeesick M, et al. Relationship of the metabolic syndrome to carotid ultrasound traits. Cardiovasc Ultrasound 2006; 4:28. DOI: https://doi.org/10.1186/1476-7120-4-28

(16). Beck P. Rating scales for mood disorders: Applicability, consist-ency and construct validity. Acta Psychiatr Scand 1988;78(Suppl 345):45-55. DOI: https://doi.org/10.1111/j.1600-0447.1988.tb08567.x

(17). Conde V. Useros E. Adaptación castellana de la escala de evalua-ción conductual para la depresión de Beck. Rev Psiquiat Psicol Med Eur Am Lat 1975; 12:217-236.

(18). Conde V, Franch JI. Escalas de evaluación comportamental para la cuantificación de la sintomatología psicopatológica en los tras-tornos angustiosos y depresivos. Madrid: Upjohn; 1984. p.62-76

(19). Bonora E, Formentini G, Calcaterra F, Lombardi S, Marini F, Ze-nari L, et al. HOMA-estimated insulin resistance is an independ-HOMA-estimated insulin resistance is an independent predictor of cardiovascular disease in type 2 diabetic subjects: prospective data from the Verona Diabetes Complications Study. Diabetes Care 2002; 25(7):1135-41. DOI: https://doi.org/10.2337/diacare.25.7.1135

(20). Correti MC, Anderson TJ, Benjamin EJ, Celermajer DC, Char-Celermajer DC, Char-bonneau F, Creager MA, et al. Guidelines for the ultrasound as-Guidelines for the ultrasound as-sessment of endothelial-dependent flow-mediated vasodilation of the brachial artery. J Am Coll Cardiol 2002; 39:257-265. DOI: https://doi.org/10.1016/S0735-1097(01)01746-6

(21). Neunteufl T, Heher S, �atzenchlager R, �olf G, �ostner �, Maurer G, et al .Late prognostic value of flow-mediated dilation in the brachial artery of patients with chest pain. Am J Cardiovasc2000; 86(2):207-210. DOI: https://doi.org/10.1016/S0002-9149(00)00857-2

(22). Al-Shali �, House AA, Hanley AJ, �han HM, Harris SB, Mama-keesick M, et al. Differences between carotid wall morphological phenotypes measured by ultrasound in one, two and three dimen-sions. Atherosclerosis 2005; 178(2):319-325. DOI: https://doi.org/10.1016/j.atherosclerosis.2004.08.016

(23). �HO. Definition Diagnosis and Classification of Diabetes Me-�HO. Definition Diagnosis and Classification of Diabetes Me-llitus and its Complications: Report of a �HO Consultation. Ge-neva: �orld Health Org; 1999.

(24). O’Brien E, Beevers G, Lip GYH. ABC of hypertension: Blood pressure measurement. Br Med J 2001; 322(7294):1167-1170. DOI: https://doi.org/10.1136/bmj.322.7295.1167

(25). Friedewald WT, Levy RI, Fredrickson DS. Estimation of the con-centration of low- density lipoprotein cholesterol in plasma, without use of preparative ultracentrifuge. Clin Chem 1972;18:499-502 DOI: https://doi.org/10.1093/clinchem/18.6.499

(26). Tapia R, Sarti E, �uri P, Ruiz-Matus C, Velásquez O. Metodo-logía epidemiológica. En: Tapia R (editor). El Manual de Salud Pública. México: Intersistemas. 2006. p.1-57.

(27). Bello M, Puentes E, Medina ME, Lozano R. Prevalencia y diag-nóstico de depresión en población adulta en México. Salud Públi-ca Méx 2005; 47 supl 1:S4-S11. DOI: https://doi.org/10.1590/S0036-36342005000100002

(28). Herva A, Rasanen P, Miettunen J, Timonen M, Laksy �, Veijola J, et al.Co-ocurrence of metabolic syndrome with depression an anxiety in young adults: The Northern Finland 1966 Birth Cohort Study. Psychosom Med 2006; 68:213-216. DOI: https://doi.org/10.1097/01.psy.0000203172.02305.ea

(29). Lenox RH, Peyser JM, Rothschild B, Shipley J, �eaver L. Fail-ure to normalize the dexamethasone suppression test: Associa-tion with length of illness. Biol Psychiatry 1985; 20(3):333-337. DOI: https://doi.org/10.1016/0006-3223(85)90064-2

(30). Nestler JE, McClanahan MA. Diabetes and adrenal disease. Baillieres Clin Endocrinol Metab 1992; 6:829-847. DOI: https://doi.org/10.1016/S0950-351X(05)80169-7

(31). Téllez JF, Morales LE, Cardiel MH. Frecuencia y factores de riesgo para depresión en pacientes con diabetes mellitus tipo 2 en un hospital de tercer nivel de atención. Med Int Méx 2001; 17(2):54-62.

(32). �rakoff LR. Glucocorticoid excess syndrome causing hyperten-sion. Cardiological Clinic 1988; 6(4):537-545. DOI: https://doi.org/10.1016/S0733-8651(18)30475-2

(33). Córdoba JA, Barquera S, Campos I, Hernández M, Rosas M, Aguilar CA, et al. Análisis de Conglomerados de factores de ries-go para enfermedades crónicas en adultos mexicanos. México: Draft; 2007

(34). Dandona P, Aljada A, Chaudhuri A, Mohanty P, Garg R. Metabo-lic Syndrome. A Comprehensive Perspective Based on Interac-A Comprehensive Perspective Based on Interac-tions Between Obesity, Diabetes, and Inflammation. Circulation 2005; 111:1448-54. DOI: https://doi.org/10.1161/01.CIR.0000158483.13093.9D

(35). Coon PJ, Rogus EM, Drinkwater D, Muller DC, Golberg AP. Role of body fat distribution in the decline in insulin sensitivity and glucose tolerance with age. J Clin Endocrinol Metab 1992; 75:1125-32. DOI: https://doi.org/10.1210/jcem.75.4.1400882

(36). Mayo �, Hayes C�, Biller BM, �libanski A, Rosenthal H, Rosenthal DI. Body fat distribution measured with CT: Correlations in healthy subjects, patients with anorexia nervosa and patients with Cushing’s syndrome. Radiology 1989; 170(2):515-518. DOI: https://doi.org/10.1148/radiology.170.2.2911678

(37). Weber B, Hentschel F, Kniest A, Deuschle M, Colla M, Lederbo-gen F, et al. Hypercortisolemic depression is associated with in-creased intra-abdominal fat. Psychosom Med 2002; 64:274-277. DOI: https://doi.org/10.1097/00006842-200203000-00010

(38). Opie LH. Metabolic Syndrome. Circulation 2007;115:e32-e35. DOI: https://doi.org/10.1161/CIRCULATIONAHA.106.671057

(39). Vakkilainen J, Steiner G, Ansquer JC, Aubin F, Rattier S, Fou-cher C, et al. Relationship between low-density lipoprotein size, plasma lipoprotein and coronary arteriophaty progression: the Diabetes and Atherosclerosis Intervention Study (DAIS). Circu-lation 2003; 107(13):1733-37 DOI: https://doi.org/10.1161/01.CIR.0000057982.50167.6E

(40). Morgan RE, Palinkas LA, Barret EL, �ingard DL. Plasma cho-lesterol and depressive symptoms in older men. Lancet 1993; 341(8837):75-79. DOI: https://doi.org/10.1016/0140-6736(93)92556-9

(41). Partonen T, Haukka J, Virtamo J, Taylor PR, Lonnqvist J. Asso-ciation of low serum total cholesterol with major depression and suicide. Br J Psychiatry 1999; 175:259-262. DOI: https://doi.org/10.1192/bjp.175.3.259

(42). Ramírez S, Jiménez NG, Lozano JJ, Rubio AF. Concentraciones sé-ricas de colesterol e intento suicida. Resúmenes del XXX Congreso Nacional de Medicina Interna. Med Interna de Méx 2007; 23:S116.

(43). Méndez GF. Causalidad en cardiologí a: conceptos en evolución. Rev Med Inst Mex Seguro Soc 2005; 43(4):357-363.

(44). Jonas BS, Franks P, Ingram DD. Are symptoms of anxiety and depression risk factors for hypertension? Longitudinal evidence from the National Health and Nutrition Examination Survey I Epidemiologic Follow-up Study. Arch Fam Med 1997; 6:43-49. DOI: https://doi.org/10.1001/archfami.6.1.43

(45). Davidson K, Jonas BS, Dixon KE, Markovitz JH. Do depres-sion symptoms predict early hypertension incidence in young adults in the CARDIA study? Coronary artery risk development in young adults. Arch Int Med 2000; 160:1495-1500. DOI: https://doi.org/10.1001/archinte.160.10.1495

(46). Eaton ��, Armenian H, Gallo J, Pratt L, Ford DE. Depression and risk for onset of type II diabetes -A prospective population-based study. Diabetes Care 1996; 19:1097-1102. DOI: https://doi.org/10.2337/diacare.19.10.1097

(47). Lustman PJ, Griffith LS, Clouse RE. Depression in adults with diabetes. Diabetes Care 1988; 11:605-612. DOI: https://doi.org/10.2337/diacare.11.8.605

Downloads

Published

2009-02-23

How to Cite

1.
López SM, Alveano J, Carranza J. Prevalence of depressive symptoms in metabolic syndrome. Rev. Fac. Nac. Salud Pública [Internet]. 2009 Feb. 23 [cited 2025 Jan. 30];26(2):1-47. Available from: https://revistas.udea.edu.co/index.php/fnsp/article/view/841

Issue

Vol. 26 No. 2 (2008)

Section

Research

License

Copyright (c) 2023 Sonia María López, Jesús Alveano, Jaime Carranza

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

The contents of the articles are the responsibility of the authors

The editorial committee has editorial independence from the National School of Public Health "Héctor Abad Gómez" of the University of Antioquia.

The editorial committee is not responsible for aspects related to copying, plagiarism or fraud that may appear in the articles published in it.

When you are going to reproduce and disclose photographs or personal data in printed or digital format, informed consent is required. Therefore, this requirement is required of the author at the time of receipt of the manuscript.

Authors are responsible for obtaining the necessary permissions to reproduce any material protected by reproduction rights.

The authors preserve the moral rights and assign the economic rights that will correspond to the University of Antioquia, to publish it, distribute electronic copies, include them in indexing services, directories or national and international databases in Open Access, under the Creative Commons Attribution license -Not Commercial-Share Equal 4.0 International Commercial (CC BY-NC-SA) which allows others to distribute, remix, retouch, and create from the work in a non-commercial way, as long as the respective credit and license are granted. new creations under the same conditions.

The authors will sign the declaration of transfer of economic rights to the University of Antioquia, after the acceptance of the manuscript.

The editorial committee reserves the right to reject the articles whose authors do not offer satisfactory explanations about the contribution of each author, to meet the criteria of authorship in the submission letter. All authors must meet the four criteria of authorship according to ICMJE: "a) .- That there is a substantial contribution to the conception or design of the article or to the acquisition, analysis or interpretation of the data. b) That they have participated in the design of the research work or in the critical review of its intellectual content. c) .- That has been intervened in the approval of the final version that will be published.d). That they have the capacity to respond to all aspects of the article in order to ensure that issues related to the accuracy or integrity of any part of the work are adequately investigated and resolved. "

Crossref
Scopus
Google Scholar
Europe PMC